B 293
Pill imprint B 293 has been identified as Oxcarbazepine 300 mg.
Oxcarbazepine is used in the treatment of seizures; bipolar disorder; anxiety; trigeminal neuralgia and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy.
Oxcarbazepine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Oxcarbazepine Images
- Imprint:
-
B 293
- Strength:
- 300 mg
- Color:
- Beige
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
magnesium silicate
titanium dioxide
FD&C Yellow No. 6
FD&C Blue No. 2
FD&C Yellow No. 5
polyvinyl alcohol
aluminum oxide
soya lecithin
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
- 51991-0293
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67877-0130 | Ascend Laboratories LLC |
| 16590-0569 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Oxcarbazepine resources
- Oxcarbazepine (Wolters Kluwer)
- Oxcarbazepine Suspension (Wolters Kluwer)
- oxcarbazepine (Cerner Multum)
- oxcarbazepine (Micromedex) - Includes Dosage Information
- Oxcarbazepine (AHFS DI)
- Oxcarbazepine (FDA)
- Oxcarbazepine Suspension (FDA)
- Oxcarbazepine (Wolters Kluwer)
Search Again
